ATE191615T1 - Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung - Google Patents

Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung

Info

Publication number
ATE191615T1
ATE191615T1 AT96904849T AT96904849T ATE191615T1 AT E191615 T1 ATE191615 T1 AT E191615T1 AT 96904849 T AT96904849 T AT 96904849T AT 96904849 T AT96904849 T AT 96904849T AT E191615 T1 ATE191615 T1 AT E191615T1
Authority
AT
Austria
Prior art keywords
tnf
amino acid
diminution
levels
acid compositions
Prior art date
Application number
AT96904849T
Other languages
English (en)
Inventor
Heinz Schneider
Original Assignee
Novartis Nutrition Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08392694 external-priority patent/US5656608B1/en
Priority claimed from GBGB9512100.0A external-priority patent/GB9512100D0/en
Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag
Application granted granted Critical
Publication of ATE191615T1 publication Critical patent/ATE191615T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96904849T 1995-02-23 1996-02-22 Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung ATE191615T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08392694 US5656608B1 (en) 1995-02-23 1995-02-23 Amino acid compositions and methods of treatment using same
GBGB9512100.0A GB9512100D0 (en) 1995-06-14 1995-06-14 Improvements in or relating to organic compounds
PCT/EP1996/000739 WO1996025861A1 (en) 1995-02-23 1996-02-22 Amino acid compositions and use thereof in clinical nutrition

Publications (1)

Publication Number Publication Date
ATE191615T1 true ATE191615T1 (de) 2000-04-15

Family

ID=26307213

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904849T ATE191615T1 (de) 1995-02-23 1996-02-22 Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung

Country Status (18)

Country Link
EP (1) EP0810829B1 (de)
JP (1) JPH11501301A (de)
KR (1) KR19980702436A (de)
CN (1) CN1175887A (de)
AT (1) ATE191615T1 (de)
AU (1) AU710527B2 (de)
BR (1) BR9607336A (de)
CA (1) CA2210499A1 (de)
CZ (1) CZ266797A3 (de)
DE (1) DE69607750T2 (de)
DK (1) DK0810829T3 (de)
ES (1) ES2145997T3 (de)
FI (1) FI972744L (de)
HU (1) HUP9800049A3 (de)
NO (1) NO973884L (de)
PL (1) PL182205B1 (de)
PT (1) PT810829E (de)
WO (1) WO1996025861A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
CA2260886A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
DE69823739T2 (de) * 1997-06-05 2005-04-28 Novartis Nutrition Ag Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen
US6310097B1 (en) * 1997-07-28 2001-10-30 Riken Protecting and survival promoting agent for central nervous cell
US6143786A (en) * 1999-02-02 2000-11-07 Novartis Nutrition Ag Oral arginine and insulin secretion
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
PH12012502440A1 (en) 2001-06-26 2013-06-17 Amgen Inc Antibodies to opgl
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
DE10257360A1 (de) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastro-intestinal verabreichbare Formulierung und deren Verwendung
US20060280776A1 (en) 2003-09-02 2006-12-14 Masafumi Koide Diet food
EP1591118A1 (de) 2004-04-27 2005-11-02 Nutri-Fit GmbH & Co. KG Verwendung von Melatonin zur Vorbeugung von postoperativen Komplikationen
KR100555904B1 (ko) * 2004-05-19 2006-03-03 주식회사 오스코텍 큰느타리버섯과 오가피의 혼합 생약재 추출물 및 이를유효성분으로 하는 골다공증 예방 및 치료용 조성물
BRPI0713642A2 (pt) * 2006-06-14 2012-10-23 Nutricia Nv composição anti-inflamatória, e, uso de uma composição
CA2994586C (en) 2008-01-04 2020-07-21 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
US20100179089A1 (en) * 2009-01-13 2010-07-15 Deutz Nicolaas E P Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
EA201691430A1 (ru) * 2009-06-08 2017-02-28 ЮСиЭл БИЗНЕС ПиЭлСи Лечение портальной гипертензии и восстановление функции печени с помощью l-орнитинфенилацетата
KR101213825B1 (ko) * 2010-07-16 2012-12-18 서울대학교산학협력단 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물
KR101758424B1 (ko) 2010-09-24 2017-07-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
KR101969199B1 (ko) 2013-03-11 2019-04-15 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 폐 기능의 개선 및 방사선 유발된 폐 합병증의 예방 및/또는 치료를 위한 물질 및 방법
EP3459540A1 (de) 2014-11-24 2019-03-27 Entrinsic Health Solutions, Inc. Aminosäurezusammensetzungen zur behandlung der symptome einer krankheit
WO2017058016A1 (en) * 2015-10-02 2017-04-06 N.V. Nutricia Glycine for use in tolerance induction in allergic patients
FR3041882B1 (fr) * 2015-10-06 2019-04-12 Universite D'angers Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion
EP3522882A4 (de) 2016-10-04 2020-06-24 The University of Florida Research Foundation Incorporated Aminosäurezusammensetzungen und verwendungen davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US4988724A (en) * 1988-12-09 1991-01-29 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
WO1993005780A1 (en) * 1991-09-27 1993-04-01 Board Of Regents, The University Of Texas System Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease

Also Published As

Publication number Publication date
HUP9800049A2 (hu) 1998-05-28
CN1175887A (zh) 1998-03-11
CZ266797A3 (cs) 1998-03-18
NO973884D0 (no) 1997-08-22
FI972744A7 (fi) 1997-08-22
EP0810829B1 (de) 2000-04-12
MX9706140A (es) 1997-11-29
BR9607336A (pt) 1997-11-25
PL182205B1 (pl) 2001-11-30
KR19980702436A (ko) 1998-07-15
AU710527B2 (en) 1999-09-23
CA2210499A1 (en) 1996-08-29
DK0810829T3 (da) 2000-08-28
DE69607750D1 (de) 2000-05-18
EP0810829A1 (de) 1997-12-10
HUP9800049A3 (en) 1999-01-28
WO1996025861A1 (en) 1996-08-29
NO973884L (no) 1997-10-17
JPH11501301A (ja) 1999-02-02
AU4879596A (en) 1996-09-11
ES2145997T3 (es) 2000-07-16
FI972744A0 (fi) 1997-06-25
PT810829E (pt) 2000-08-31
PL321238A1 (en) 1997-11-24
DE69607750T2 (de) 2000-08-31
FI972744L (fi) 1997-08-22

Similar Documents

Publication Publication Date Title
ATE191615T1 (de) Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
IL112111A0 (en) Peptide derivatives and pharmaceutical compositions containing them
BG103335A (en) Application of fumaric acid derivatives
CA2371696A1 (en) Composition for an infant formula having a low threonine content
NO953781L (no) Terapeutisk anvendelse av keratinocyttvekstfaktor
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
EP0797999A3 (de) Fettleibigkeitprotein-Formulierungen
BR9610480A (pt) Inibição do fator alfa de necrose tumoral
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
FR2746101B1 (fr) Composes bicycliques-aromatiques
WO2006023665A3 (en) Il-1 antagonist formulations
MXPA99010523A (es) Metodos para mejorar el funcionamiento del tractogastrointestinal superior.
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
MXPA02012064A (es) Complejos de farmaco macromoleculares y composiciones que los contienen.
FR2746098B1 (fr) Composes propynyl biaromatiques
Wildburger et al. Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro
WO2002058589A3 (en) Agents and methods for promoting bone growth
EP0821969A3 (de) Arzneimittelzusammensetzung enthaltend TCF-II
DE69430416D1 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
BRPI0409424B8 (pt) composição farmacêutica para administração parenteral, e, usos de uma partícula coloidal e de partículas coloidais e uma proteína ou um polipeptídeo
WO2003068160A3 (en) Use of insulin-like growth factor binding protein 3 (igf-bp3) for inhibition of tumor growth
DK521389A (da) Praeparat til behandling af adrenoleukodystrofi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee